Hyperfine Past Earnings Performance

Past criteria checks 0/6

Hyperfine's earnings have been declining at an average annual rate of -7.4%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 58.3% per year.

Key information

-7.4%

Earnings growth rate

70.5%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate58.3%
Return on equity-70.3%
Net Margin-309.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Analysts Are Updating Their Hyperfine, Inc. (NASDAQ:HYPR) Estimates After Its Third-Quarter Results

Nov 15
Analysts Are Updating Their Hyperfine, Inc. (NASDAQ:HYPR) Estimates After Its Third-Quarter Results

Hyperfine appoints Maria Sainz as President, CEO

Oct 06

Hyperfine GAAP EPS of -$0.33 misses by $0.06, revenue of $1.53M misses by $0.47M

Aug 10

Hyperfine stock plunges 14% as CEO Dave Scott steps down

Jun 29

Hyperfine (NASDAQ:HYPR) Is In A Good Position To Deliver On Growth Plans

Apr 04
Hyperfine (NASDAQ:HYPR) Is In A Good Position To Deliver On Growth Plans

Hyperfine: MR Imaging In A Swoop

Mar 09

Revenue & Expenses Breakdown

How Hyperfine makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NasdaqGM:HYPR Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2413-412723
30 Jun 2412-412723
31 Mar 2412-422823
31 Dec 2311-443022
30 Sep 2310-473222
30 Jun 2310-493223
31 Mar 238-624025
31 Dec 227-734728
30 Sep 226-865532
30 Jun 224-895831
31 Mar 223-815030
31 Dec 211-653826
30 Sep 211-462421
30 Jun 211-351718
31 Mar 211-261015
31 Dec 200-23815

Quality Earnings: HYPR is currently unprofitable.

Growing Profit Margin: HYPR is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: HYPR is unprofitable, and losses have increased over the past 5 years at a rate of 7.4% per year.

Accelerating Growth: Unable to compare HYPR's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: HYPR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.9%).


Return on Equity

High ROE: HYPR has a negative Return on Equity (-70.32%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 07:56
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hyperfine, Inc. is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yuan ZhiB. Riley Securities, Inc.
Vijay KumarEvercore ISI
Xuyang LiJefferies LLC